Cinevista Limited

NSE:CINEVISTA.NS

18.67 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q32018 Q22018 Q12017 Q12015 Q42015 Q32015 Q12014 Q42014 Q32014 Q12013 Q42013 Q3
Revenue 0.2290.070.0324.3030080010.20005.0241.2772.079056.47876.47246.05246.496123.009135.29100119.7252.422116.984103.402157.773109.667131.57590.127
Cost of Revenue 7.6183.0886.9322.3224.696274.8670.8620.4231.10111.194.1973.7361.584466.6992.5723.5883.34349.6153.86333.61325.1997.608106.6670081.76627.78890.11279.091131.89380.1393.77862.278
Gross Profit -7.389-3.018-6.91.981-4.696-274.8677.138-0.423-1.101-0.99-4.197-3.736-1.584-461.675-1.295-1.509-3.3436.86822.60912.43921.30625.40128.6240037.95424.63426.87224.31125.8829.53737.79727.849
Gross Profit Ratio -32.266-43.114-215.6250.46000.89200-0.097000-91.894-1.014-0.72600.1220.2960.270.4580.2060.212000.3170.470.230.2350.1640.2690.2870.309
Reseach & Development Expenses 000000000000000000000000000000000
General & Administrative Expenses 00000373.435000000000000000000000000000
Selling & Marketing Expenses 000000.0660000.0990000.0870000.109000000000000000
SG&A 003.9064.01917.899373.50116.6645.0334.4260.09912.678010.0420.0870000.10900000003.6710000000
Other Expenses 0.1530.2070.1863.2490.6648.9560.0215.891.835-5.4510.6074.84811.62641.840.0430.5530.674-0.6530.4320.0070.5560.5040.6010076.63715.72317.19727.57715.47919.15929.08419.064
Operating Expenses 7.61811.1573.9069.90913.36590.99118.545.4564.829-64.79113.2575.96911.62611.47210.558.2067.2156.98114.9514.86413.57615.8215.7540076.63715.72317.19727.57715.47919.15929.08419.064
Operating Income -7.389-3.018-10.806-4.679-17.397-374.097-11.380.435-2.99461.815-12.643-71.121-11.626-7.563-9.273-6.127-7.215-0.1137.659-2.4257.739.58112.8700-48.7450.0460.358-3.2660.1160.5871.0640.128
Operating Income Ratio -32.266-43.114-337.688-1.08700-1.423006.06000-1.505-7.262-2.9470-0.0020.1-0.0530.1660.0780.09500-0.4070.0010.003-0.0320.0010.0050.0080.001
Total Other Income Expenses Net -8.343-7.535-6.136-5.642-10.618-26.865-19.519-15.585-13.151-77.748-13.693-15.275-7.876-36.576-11.106-11.08-6.46-10.689-10.654-12.292-9.661-9.244-12.7580038.586-8.865-9.317-5.717-10.285-9.791-7.649-8.657
Income Before Tax -15.732-10.553-16.942-10.321-28.015-400.962-30.899-15.15-16.145-15.933-26.336-86.396-19.502-44.139-20.379-17.207-13.675-10.802-2.995-14.717-1.9310.3370.11200-0.0970.0460.358-8.9830.1160.5871.0640.128
Income Before Tax Ratio -68.699-150.757-529.438-2.39900-3.86200-1.562000-8.786-15.958-8.2770-0.191-0.039-0.32-0.0420.0030.00100-0.0010.0010.003-0.0870.0010.0050.0080.001
Income Tax Expense 09.1670.3280.0770.12-183.3110.1830.337016.40.14400-24.2670.0430.5530.6740.0160.4320.2760.5560.5040.1700-0.0350.0010.1761.2050.02700.510
Net Income -15.732-19.719-16.942-10.321-28.015-217.65-30.899-15.15-16.145-32.51-26.48-86.396-19.502-44.153-20.379-17.207-13.675-10.818-2.995-14.993-1.9310.337-0.05800-0.0620.0450.182-10.1870.0890.5870.5540.128
Net Income Ratio -68.699-281.7-529.438-2.39900-3.86200-3.187000-8.788-15.958-8.2770-0.192-0.039-0.326-0.0420.003-000-0.0010.0010.002-0.0990.0010.0050.0040.001
EPS -0.27-0.34-0.29-0.18-0.49-3.79-0.54-0.26-0.28-0.57-0.46-1.5-0.34-0.77-0.35-0.3-0.24-0.19-0.052-0.26-0.0340.006-0.0010.0030.001-0.0010.0010.003-0.180.0020.010.010.002
EPS Diluted -0.27-0.34-0.29-0.18-0.49-3.79-0.54-0.26-0.28-0.57-0.46-1.5-0.34-0.77-0.35-0.3-0.24-0.19-0.052-0.26-0.0340.006-0.0010.0030.001-0.0010.0010.003-0.180.0020.010.010.002
EBITDA -7.094-2.735-10.518-4.48-17.235-373.978-11.170.858-2.591-6.735-12.071-70.534-10.042-29.898-7.225-3.556-4.5421.69110.463-0.05610.6212.8716.1640015.26813.75314.2515.43815.09214.92113.49413.935
EBITDA Ratio -30.978-39.071-328.688-1.04100-1.39600-0.66000-5.951-5.658-1.7100.030.137-0.0010.2280.1050.119000.1280.2620.1220.0530.0960.1360.1030.155